CHRISTINE MILLER: Open Payments
NPI 1194201020 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 116 payments from 16 companies in 2025. Trend: 2023 $2,913 · 2024 $2,773 · 2025 $2,493
Food & beverage: $2,421Education: $71
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $459 |
| Teva Pharmaceuticals USA, Inc. | 12 | $322 |
| Vanda Pharmaceuticals Inc. | 9 | $297 |
| Axsome Therapeutics, Inc. | 6 | $225 |
| Otsuka America Pharmaceutical, Inc. | 12 | $184 |
| Lundbeck LLC | 11 | $175 |
| Neurocrine BioSciences, Inc. | 9 | $168 |
| ABBVIE INC. | 13 | $166 |
| Corium, LLC | 7 | $128 |
| E.R. Squibb & Sons, L.L.C. | 6 | $100 |
Products named: CAPLYTA, FANAPT, REXULTI, Auvelity, AUSTEDO XR, INGREZZA, VRAYLAR, Azstarys.
Industry payments across OH — which companies pay providers there.
